Predict your next investment

BUSINESS PRODUCTS & SERVICES
sdvg.org

See what CB Insights has to offer

Board of Directors

2

San Diego Venture Group Board of Directors

2 Board of directors

San Diego Venture Group has 2 board of directors, including Derek Barclay.

Name

Firm

Work History

Other Seats

Derek Barclay

Cofounder & CEO, First Look Approval; Managing Partner & COO, BounceBack Funding; Cofounder & CEO, BounceBack Finance; VP,Sales & Marketing, Coastal Payroll Services

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018. Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Aspen Neuroscience

Name

Derek Barclay

Drew Spaventa

Firm

Work History

Cofounder & CEO, First Look Approval; Managing Partner & COO, BounceBack Funding; Cofounder & CEO, BounceBack Finance; VP,Sales & Marketing, Coastal Payroll Services

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018. Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Other Seats

Aspen Neuroscience

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.